Tandem Diabetes Care
TNDM
TNDM
84 hedge funds and large institutions have $170M invested in Tandem Diabetes Care in 2015 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
48% less call options, than puts
Call options by funds: $515K | Put options by funds: $982K
Holders
84
Holding in Top 10
–
Calls
$515K
Puts
$982K
Top Buyers
| 1 | +$2.36M | |
| 2 | +$1.76M | |
| 3 | +$1.43M | |
| 4 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$1.22M |
| 5 |
SAM
Symphony Asset Management
San Francisco,
California
|
+$770K |
Top Sellers
| 1 | -$2.67M | |
| 2 | -$2.12M | |
| 3 | -$2.02M | |
| 4 |
JP Morgan Chase
New York
|
-$1.29M |
| 5 |
D.E. Shaw & Co
New York
|
-$807K |